New York ENT Specialist Dr. Edward Shin’s CV is exemplary of his distinguished career as an NY ENT Specialist.

Otolaryngology Center
TEL:646.943.7985310 14Th STREET, SIXTH FLOOR NEW YORK, NEW YORK, 10003FAX:212.979.4315

Manhattan ENT Doctor Edward Shin MD CV

EDUCATIONAL / ACAMEDIC HONORS AND AWARDS POST - GRADUATE TRAINING

1988 - 1992 Bristol - Myers Squib National Merit Scholarship
1988 - 1992 Echols Scholar
1989 University of Virginia: Intermediate Honors
1990 - 1992 University of Virginia: Participant in Distinguished Majors Program in Biology
1991 - 1992 Howard Hughes Research Apprentice
1992 2nd Place at Katz Undergraduate Research Symposium
1992 Samuel Miller Scholarship for Excellence in the Biological
Sciences
1992 - 1993 Stanford Medical Scholar’s Program
2002 Resident Travel Grant to American Academy of Otolaryngic Allergy
2004 - 2005 Teacher of the Year, Department of Otolaryngology, Mount Sinai
2006 - 2007 Teacher Award, Department of Otolaryngology, Mount Sinai Graduating Class of 2007
2010 Teacher of the Year Award, Department of Otolaryngology, New York Eye and Ear Infirmary

 

EDUCATION

Sept 1988 - June 1992 University of Virginia
BA with High Honors
PO Box 400203
Charlottesville, Virginia 22904
Sept 1992 - June 1997 Stanford School of Medicine
M.D.
251 Campus Drive, MSOB x341
Stanford, California 94305
July 1997 - June 1998 Internship: General Surgery
Box 0470 S 343
Department of General Surgery
University of California, San Francisco
San Francisco, California
Chairwoman: Dr. Nancy Ascher
July 1998 - June 2002 Residency: Otolaryngology
400 Parnassus Ave, Suite A - 730
Department of Otolaryngology - Head and Neck Surgery
University of California, San Francisco
San Francisco CA 94143 - 0342
Chairman: Dr. David Eisele

 

POST - GRADUATE TRAINING

2000 Training in Clinical Research, Clinical Research Workshop, UCSF
2003 Clinical Gene Transfer Comprehensive Review Course, American Society of Gene Therapy, Washington, DC, June 3 - 4, 2003
2003 - 2004 Masters in Clinical Research, Mount Sinai School of Medicine, NY
2005 Investigator Training Program, Metropolitan Hospital, NY

 

HOSPITAL APPOINTMENTS

Dec 2007 - Present Assoc Attending
Department of Otolaryngology
New York Eye and Ear Infirmary
New York, New York 10013
July 2003 - Dec 2007            Regional Director
Department of Otolaryngology
Elmhurst Hospital Center and Queens Hospital Center
Elmhurst, New York 11373
October 2002 - June 2003   Clinical Assistant
Department of Otolaryngology
Elmhurst Hospital Center
Elmhurst, New York 11373
October 2002 - June 2003     Clinical Assistant
Department of Otolaryngology
Queens Hospital Center
Jamaica, New York 11432

 

ACADEMIC APPOINTMENTS

Jan 2017 - Present Vice-Chair of Otolaryngology, Mount Sinai Downtown Campus
April 2011 - Dec 2016

Chair, Department of Otolaryngology, New York Eye and Ear Infirmary

Jan 2013 - July 2014 Chair, Department of Otolaryngology, New York Medical College
April 2011 - Jan 2013 Acting Chair, Department of Otolaryngology, New York Eye and Ear Infirmary.
April 2011 - Jan 2013 Acting Chair, Department of Otolaryngology, New York Medical College
April 2011 - Jan 2013 Program Director, Department of Otolaryngology, New York Eye and Ear Infirmary
Dec 2007 - March 2011 CO - Director of Residency Education, Department of Otolaryngology, New York Eye and Ear Infirmary
Jan 2014 - Present Professor of Otolaryngology, Icahn School of Medicine at Mount Sinai
Sept 2012 - Dec 2013 Professor of Clinical Otolaryngology New York Medical College
Dec 2007 - Sept 2012 Associate Professor of Clinical Otolaryngology New York Medical College
July 2003 - Dec 2007 Assistant Professor
Department of Otolaryngology
Mount Sinai School Of Medicine
New York, New York 10029
September 2002 to June 2003 Clinical Instructor
Department of Otolaryngology
Mount Sinai School Of Medicine
New York, New York 10029

 

BOARD CERTIFICATION

May 2003 Certified, American Board of Otolaryngology

 

FELLOWSHIP, AWARDS, GRANTS AND CONTRACTS

  • Shin EJ, Menaker M, Vogelbaum M: Neural Transplantation of SCN in Mice. Presented at Katz Undergraduate Research Symposium, 1992. 2nd place.
  • Shin EJ, Choi B, Ebert O, Chang JI, Genden E, Woo S Interferon - alpha Protects Head and Neck Squamous Cells from Oncolytic Vesicular Stomatitis Virus in a Dosedependent Manner. Presented at COSM, May 2005, awarded 2nd prize.
  • Shin EJ Collaborator Intervention models for thyroid proliferative disease using a bioactive food component. RO1 NIH 1.5 million in funding over five years.
  • Shin EJ   Principal Investigator.  NYMC intramural grant investigating Molecular Pathogenesis of Papillary Thyroid Cancer.  ($10,000), awarded December 2010.

LICENSURE

  • May 2001
  • March 2002

PROFESSIONAL SOCIETY MEMBERSHIP

1997 - Present            American Medical Association
1998 - Present     American Academy of Otolaryngology - Head and Neck Surgery
2004 - Present     New York Head and Neck Society
2004 - Present     Fellow, American College of Surgeons

 

SERVICE TO PROFESSIONAL PUBLICATIONS

2000 Ad Hoc Reviewer, ENT Journal
2004 Ad Hoc Reviewer, Hong Kong Council of Grants
2005 Reviewer, Laryngoscope Journal
2008 Ad Hoc, Reviewer, Neoplasia Journal

 

EDUCATIONAL ACTIVITIES

Medical Students
Teaching:
2002 - 2007 Teaching Mount Sinai Medical Student
2 hours per week
2007 - Present Teaching NYEE Otolaryngology residents
4 hours per week
Curriculum Development
1993 - 1994 Teaching Assistant of Molecular Biology 5 hours per week
 
Residents
Teaching:
2002 - 2007 Weekly formal teaching on otolaryngology
2 hours per week
2007 - Present Weekly formal teaching on otolaryngology at NYEE.
2 hours every week.
Curriculum Development
2007 - Present Coordinator Otolaryngology Resident Curriculum at NYEE.
2002 - 2007 Instituted self teaching curriculum on otolaryngology. Mount Sinai
2001 - 2002 Organized Grand Rounds
1 hour per week
2001 - 2002 Setting up anatomy course
1 hour per week
2001 - 2002 Assisted Clinical Exam for Head and Neck
1 hour per week

 

ADMINISTRATIVE RESPONSIBLITIES

2003 - 2007 Medical Board, Elmhurst Hospital Center
2003 - 2007 Surgical Evaluation Committee, Elmhurst Hospital Center
2003 - 2007 Chairman, Otolaryngology Quality Management Committee, Elmhurst Hospital Center
2003 - 2007 Electronic Medical Records - Design and implementation of electronic medical record specific for Otolaryngology Outpatient/Consult/inpatient services at Queens and Elmhurst hospitals
2003 - 2007 Equipment revitalization at Elmhurst Clinics. Acquired 2 new Zeiss wall mounted microscopes, Mindstream console capable of taking digital photos and video. Continued repair and upgrades to endoscopic equipment, and clinical equipment. (total cost roughly $90,000)
2003 - 2007 Additional exam room constructed and equipped for increased patient flow.
2004 - 2007 OR Utilization Committee, Elmhurst Hospital Center
2004 - 2007 RTOG Head and Neck Subcommittee for Translational
Research
2004 - 2007 OR Scheduling. Design pilot and implementation of electronic medical record OR scheduling to aid in streamlining clearance process of indigent population. Now
being implemented across all surgical services at Elmhurst Hospital
2004 - 2007 Departmental increase in Operative time. Negotiated increase of 1 full day in operative time with the opening of new operating rooms
2004 - 2007 Acquisition of new OR equipment. Systematic replacement and increase of new operative sets. Obtained 2nd Head and Neck Set. Medialization Laryngoplasty Set. Two New Sinus Sets with Endoscopes and Frontal Sinus Set to supplement intraoperative imaging system and resident training (GE instatrak).
2004 - 2007 Cost Saving initiative for Craniofacial and Mandibular sets resulting in over $100,000 saving for the hospital.
2004 - 2007 Implementation of Surgitrack. Online program to track and streamline financial and anesthesia clearance process.
2006 - 2007 Patient Safety Committee, Elmhurst Hospital Center
2008 - 2010 Associate Residency Program Director Department of Otolaryngology, NYEE Infirmary
2008 - Present Grand Rounds Coordinator, NYEE Infirmary. Department of Otolaryngology.
2008 - Present Department Representative to Graduate Medical Education Committee, NYEE Infirmary
2009 - Present Director of Medical Student Rotations, NYEE Infirmary
2009 - Present Graduate Medical Advisory Committee NYMC
2009 - Present Director of ENT Clinics, NYEE. 
2009 - Present Ambulatory Care Committee Member, Dept of ENT representative, NYEE.
2010 - Present Co - Chair for steering committee for NYEE NPO/IPA
2010 - Present NYEE Capital Budget committee member
2010 - Present NYEE ICD10 implementation committee member
2011 - Present NYEE Meaningful Use committee member
2011 - Present Executive Committee Member, Department of Otolaryngology
2011 - Present Ambulatory EMR committee member

 

INVITED LECTURES:

  • Sinonasal malignancy and orbital preservation: Does IMRT make a difference? Grand Rounds, Mount Sinai Department of Otolaryngology, New York, NY January 2003.
  • The Role of Combined Modality Therapy in Locally Advanced Squamous Cell Carcinomas of the Head and Neck. Grand Rounds Mount Sinai Department of Otolaryngology, New York, NY July 2004.
  • The Basis of Immune Dysfunction in Head and Neck Cancer Patients Department of Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, NY August 2004.
  • The Neck. 3rd International Target Delineation Symposium for IMRT/3D CRT Treatment Planning, Organized by The University of Texas MD Anderson Cancer Center, Vail, Colorado February 2005.
  • Oral Cavity and Oropharynx Cancer. 3rd International Target Delineation Symposium for IMRT/3D CRT Treatment Planning, Organized by The University of Texas MD Anderson Cancer Center, Vail, Colorado February 2005.
  • Thyroid Malignancy. Presented at 3rd International Target Delineation Symposium for IMRT/3D CRT Treatment Planning, Organized by The University of Texas MD Anderson Cancer Center, Vail, Colorado February 2005.
  • The Neck. IMRT Symposium. Taipei University, Taipei, Taiwan June 2005.
  • Surgical Perspective: Oral Cavity and Oropharynx. IMRT Symposium. Taipei University, Taipei, Taiwan June 2005.
  • Oral Cavity and Oropharynx Cancers. Presented at 4th International Target Delineation Symposium for IMRT/3D CRT Treatment Planning, organized by The University of Texas MD Anderson Cancer Center, Half Moon Bay, California February 2006.
  • Oral Cavity Carcinoma. IMRT Symposium. Taipei University, Taipei, Taiwan March 2006.
  • Oral Cavity Cancer RGCON 6th Annual International Conference: Head and Neck Cancer, Delhi, India March 2006.
  • Management of parapharyngeal space tumors. XVI Congreso Integrado Latinoamericano de Cancerologia, XII Congreso Venezolano de Oncologia y VI Congreso Venezolano de Radioterapia Oncologica, Margarita Island, Venezuela October 2006
  • HPV in the etiology of head and neck cancers. XVI Congreso Integrado Latinoamericano de Cancerologia, XII Congreso Venezolano de Oncologia y VI Congreso Venezolano de Radioterapia Oncologica, Margarita Island, Venezuela October 2006
  • Cancer of the Salivary Glands. 16th Annual Course Minimally Invasive and Endoscopic Head and Neck Surgery. Contemporary Approaches to Head and Neck Surgery. Mount Sinai School of Medicine, New York, NY, February 2007.
  • Cancer of the Salivary Glands. Resident teaching rounds. Department of Radiation Oncology. Mount Sinai School of Medicine, New York, NY March 2007.
  • HPV and Head and Neck Cancer, UCSF Otolaryngology Update, San Francisco, California November 2007.
  • Use of PET/CT in the Management of Head and Neck Cancer, UCSF Otolaryngology Update, San Francisco California November 2007
  • HPV and Head and Neck Cancer, Montefiore Medical Center Grand Rounds, Bronx, NY March 2008.
  • Use of PET/CT in the Management of Head and Neck Cancer. Montefiore Medical Center Grand Rounds, Bronx, NY November 2009.
  • Oral Cavity Carcinoma and Neck Dissections. Academic Conference. Department of Otolaryngology, NYEE  New York, NY July 2011.

BIBLIOGRAPHY:

PEER - REVIEWED PUBLICATIONS:

  1. Lin YH, Shin EJ, Campbell MJ, Niederhuber JE: Transcription of the blk Gene in Human B Lymphocytes is Controlled by Two Promoters. J Biol Chem, 270(43)25968 - 25975.
  2. Utley DS, Shin EJ, Terris DJ: A Rational and Cost Effective Approach to the Treatment of Snoring, the Upper Airway Resistance Syndrome, and Mild and Moderate Obstructive Sleep Apnea Syndrome. Laryngoscope, 107:726 - 734, 1997.
  3. Shin EJ, Murr A: Managing Epistaxis. Current Opinion in Oto - HNS, 8:37 - 42, 2000. Edward J. Shin, M.D. Rev. 11/15/08 Page 7
  4. Shin EJ, Lalwani AK, Dowd CF: Role of Angiography in the Evaluation of Patients with Pulsatile Tinnitus. Laryngoscope, 2000;110(8):1346 - 8.
  5. Mafong DD, Shin EJ, Lalwani AK: Evaluation of children with SNHL. Laryngoscope, 2002 112(1)1 - 7.
  6. Shin EJ, Guertler N, Kim E, Lalwani AK: Screening of middle ear effusion for the common sinus pathogen Bipolaris Euro Arch of Oto - Rhino - Laryngol 2003 Feb: 260(2):78 - 80.
  7. Xia P, Lee N, Liu Y - M, Poon I, Akazawa P, Quivey JM, Shin EJ, Verhey LJ: A Study of Standardized Planning Constraints for Treatment of Nasopharyngeal Carcinoma Using a Commercial Inverse Treatment Planning System. Int J
    Radiat Oncol Biol Phys. 2004 Jul 1:59(3):886 - 96.
  8. Gurney TA, Eisele DW, Weinberg V, Shin EJ, Lee N Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope. 2005 Jul;115(7):1278 - 82.
  9. Shin EJ, Chang JI, Choi B, Ebert O, Genden E, Woo S Fusogenic vesicular stomatitis virus for the treatment of head and neck squamous carcinomas. Otolaryngol Head Neck Surg. 2007 May 136(5):811 - 7.
  10. Shin EJ, Wanna G, Choi B, Ebert O, Genden E, Woo S Interleukin - 12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma. Laryngoscope 2007 Feb:117(2) 210 - 4.
  11. Sung K, Wanna G, Choi B, Genden EM, Shin EJ VSV and cisplatin eradicates squamous cancer cells. Laryngoscope. 2008 Feb:118(2)237 - 242.
  12. Adappa ND, Sung CK, Choi B, Huang TG, Genden EM, Shin EJ The administration of IL - 12/GM - CSF and Ig - 4 - 1BB ligand markedly decreases murine floor of mouth squamous cell cancer. Otolaryngol Head Neck Surg. 2008 Sep;139(3):442 - 8
  13. Lee N., Shin EJ. Synovial Sarcoma of the Head and Neck. Expert Rev Anticancer Ther. 2008 Mar;8(3):371 - 3
  14. Caria N, Setton J, Shin E and Lee N. Intensity - modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: a clinical review. The Asia Pacific Journal of Oncology and Hematology.. 2009
  15. Theodore S. Nowicki, Nicolas T. Kummer, Codrin Iacob, Nina Suslina, Augustine Moscatello,  Steven Schaefer,  Stimson Schantz, Edward Shin, Raj K. Tiwari, and Jan Geliebter.. uPA and uPAR Promote Invasion and Metastasis in Papillary Thyroid Carcinoma Cells. Laryngoscope. 2010 120:1383 - 90.
  16. Theodore S. Nowicki, Hong Zhao, Zbigniew Darzynkiewicz,, Stimson Schantz, Edward Shin,  Raj K. Tiwari, and Jan Geliebter.  Down - regulation of uPAR inhibits migration, invasion, proliferation, and FAK/PI3K/Akt signaling in papillary thyroid carcinoma cells.  2011. Cell Cycle, Jan 1;10(1):100 - 7.
  17. Megwalu U, Shin EJ  Second Primaries after Major Salivary Gland Cancer.  Otolaryngol Head Neck Surg.  2011 Apr 5

Book Chapters

  1. Shin EJ: Management of tumors in the parapharyngeal space. In: Lalwani, Current Diagnosis & Treatment in Otolaryngology - Head & Neck Surgery. McGraw Hill, 2004.
  2. Lee N, Shin EJ: Skull base tumors and Radiation Therapy In Cummings, Otolaryngology/Head & Neck Surgery (Mosby) 2004.
  3. Shin EJ: Management of tumors in the parapharyngeal space. In: Lalwani, Current Diagnosis & Treatment in Otolaryngology - Head & Neck Surgery (2nd edition). McGraw Hill.
  4. Section Editor: General Otolarygology, New York Eye and Ear Infirmary Handbook. 2010
  5. Shin EJ Anatomy of the head and neck. In: Scalfani: NYEE Handbook of Otolaryngology 2010
  6. Shin EJ Anticrobial Therapy in the head and neck. In: Scalfani: NYEE Handbook of Otolaryngology 2010
  7. Lee N, Shin EJ, Chao C IMRT In: Berneir, Head and Neck Cancer

ABSTRACTS (Presented at National meetings):

  • Lien TH, Shin EJ, Campbell MJ, Niederhuber JE: Immunotherapy of Lung Cancer with Il - 2 Producing, Xenogeneic Cells Encapsulated in Microspheres. Presented at Third International Meeting for Gene Therapy of Cancer, 1995.
  • Utley DS, Shin EJ, Terris DJ: A Rational and Cost Effective Approach to the Treatment of Snoring, the Upper Airway Resistance Syndrome, and Mild and Moderate Obstructive Sleep Apnea Syndrome. Presented at the Combined Otolaryngology Spring Meeting, 1996.
  • Yao M, Shin EJ, Utley DS, Terris DJ: Cephalometry and the Prediction of Outcomes in Patients with Obstructive Sleep Apnea. American Academy of Otolaryngology – Head and Neck Surgery, September 1997.
  • Johnson J, Shin EJ, Bikhazi N, Lee KC, Mandpe AH: Outpatient Tonsillar Biopsy Safely Determines HIV Viral Load. Presented at Annual Meeting of American Academy of Otolaryngology – Head and Neck Surgery, New York, NY, September 1999.
  • Lee KC, Shin EJ, Mandpe AH, Bikhazi N: The Use of Coblation Technology for Traditional Tonsillectomy. Presented at Annual Meeting of American Academy of Otolaryngology – Head and Neck Surgery, New York, NY, September 1999.
  • Shin EJ, Lalwani AK, Dowd C: Role of Angiography in the Evaluation of Patients with Pulsatile Tinnitus. Presented at the Combined Otolaryngology Spring Meeting, Orlando, Florida, 2000.
  • Shin EJ, Mandpe A, Tsung K, Norton JA: Interleukin - 12 partially eradicates established SCC VII. Presented at the Combined Otolaryngology Spring Meeting, Palm Desert, CA 2001.
  • Shin EJ, Mafong D, Lalwani AK: Evaluation of children with SNHL. Presented at the Combined Otolaryngology Spring Meeting, Palm Desert, 2001.
  • Shin EJ, Kim E, Catten M, Lalwani AK: PCR assay for Bipolaris. Presented at the Annual Meeting of American Academy of Otolaryngology - Head and Neck Surgery, Denver, Colorado, 2001.
  • Lee N, Zhu N, Baker L, Akazawa M, Shin EJ: How Much Intrafraction Patient Movement is Observed in Head and Neck Cancer Patients Undergoing Intensity - Modulated Radiation Therapy (IMRT)? Presented at ASTRO, Utah, 2003.
  • Shin EJ, Ebert O, Choi B, Garcia A, Woo SL Urken ML, Genden E Vesicular Stomatitis Virus and Head and Neck Cancer. Presented at 6th International Meeting for Head and Neck Cancer, Washington DC, August 2004.
  • Gurney TA, Eisele DW, Shin EJ, Weinberg V, Lee N Treatment Outcomes of Patients with Adenoid Cystic Carcinoma of the Major Salivary Glands. Presented at Western Section Conference, The Triological Society, Los Angeles, CA, February 2005.
  • Shin EJ, Choi B, Ebert O, Chang JI, Genden E, Woo S Interferon - alpha Protects Head and Neck Squamous Cells from Oncolytic Vesicular Stomatitis Virus in a Dosedependent Manner. Presented at COSM, Boca Raton, FL, May 2005, awarded 2nd prize.
  • Shin EJ, Choi B, Huang T - G, Wanna GB, Genden E, Woo S Genetically modified fibers in recombinant adenoviral vectors enhance viral transduction in head and neck squamous carcinoma lines. Presented at COSM, Boca Raton, FL, May 2005.
  • Shin EJ, Choi B, Chang JI, Ebert O, Genden E, Woo S Fusogenic VSV Preferentially Eradicates Head & Neck Squamous Cell Carcinoma but not Normal Epithelial Cells. Poster presentation at annual AAO - HNS meeting, Los Angeles, CA, September 2005.
  • Eloy JA, Genden EM, Shin EJ, Jacobsen AJ Preoperative Selective Venous Sampling for Localization of Parathyroid Adenoma. Poster presentation at annual AAO - HNS meeting. Los Angeles, CA, September 2005.
  • Shin EJ, Choi B, Wanna G, Ebert O, Genden E, Woo S Interleukin - 12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma. Presentation at annual Triological Society Meeting, Chicago, May 2006.
  • Dhir K, Altman J, Shin EJ A rare clinical presentation of bilateral intratonsillar abscesses. Eastern Section Triological Society Meeting, Toronto, Ontario, January 2006.
  • Nurse L, Shin EJ Atypical schwannoma in the floor of mouth. Presentation at Triological Society Meeting, Chicago, May 2006.
  • Shin EJ, Sung K, Choi B, Genden E, Woo S Oncolytic VSV for the treatment of medullary thyroid cancer. Presented at Eastern Section Triological Society Meeting, San Diego, CA, February 2007.
  • Sung K, Wanna G, Choi B, Genden EM, Shin EJ VSV - IL - 12 and cisplatin eradicates squamous cancer cells but not normal epithelial cells. Presented at 110th Triological Annual Meeting, San Diego , April 2007
  • Adappa N, Choi B, Sung K, Genden E, Woo S, Shin EJ Combined adenoviral based immunotherapy in the treatment of head and neck cancer. Presented at annual AAOHNS meeting, Washington DC, 2007.
  • Cheng J, Love L Shin EJ Case Report: Postoperative Ingested Esophageal Throat Pack (poster) Eastern Section Meeting January 25 - 27, 2008 Philadelphia, Pennsylvania.
  • Adappa N, Sung K, Shin EJ PREOPERATIVE PROTHROMBIN TIME/PARTIAL THROMBOPLASTIN TIME AS A PREDICTOR OF POSTOPERATIVE HEMORRHAGE AFTER TONSILLECTOMY (Poster) Twenty - third Annual Meeting of the American Society of Pediatric Otolaryngology, May 2 - 4, 2008, Orlando, Florida.
  • Pelosi S, Love L, Teng M, Shin EJ Small Cell Carcinoma of the Larynx and Hypopharynx: A case report and review of the literature. (Poster) Presented annual AAO - HNS meeting Chicago 2008.
  • Nowicki TS, Kummer N, Suslina N, Iacob, C, Schaefer S, Schantz S, Shin EJ, Tiwari R Urokinase and urokinase receptor expression in papillary thyroid carcinoma: degradation of extracellular matrix components and potential biomarkers. World Congress on Thyroid Cancer 2009.
  • Joseph Rousso, Jean - Paul Azzi, E. Ashlie Darr, Jan Geliebter, Shin EJ. A retrospective analysis of Braf V600E mutation and its diagnostic implications in 99 total thyroidectomy specimens. For presentation at the 2012 Combined Sections Meeting at the Triological Society Conference.

  • E. Ashlie Darr, Theodore S. Nowicki, Melanie MacEwan, Julie Dunbar, Nicolas Kummer, Nina Suslina, Codrin Iacob, Shin EJ, Stimson Schantz, Raj Tiwari, Jan Geliebter. BRAFV600E status predicts higher uPA levels in papillary thyroid cancer. Poster presented at AACR 102nd Annual Meeting 2011 in Orlando, FL.

  • Melanie MacEwan, Vikas Mehta, E. Ashlie Darr, Suqing Xie, Theodore S. Nowicki, Codrin Iacob, Nina Suslina, Ismael Reyes, Stimson Schantz, Shin EJ, Raj Tiwari, Jan Geliebter. Increased expression of KLK7 and KLK10 in papillary thyroid cancer. Poster presentation at AACR 102nd Annual Meeting 2011 in Orlando, FL.